Format

Send to

Choose Destination
Methods Mol Biol. 2018;1692:213-219. doi: 10.1007/978-1-4939-7401-6_18.

Circulating Tumor Cells.

Author information

1
Department of Gastrointestinal, Thoracic and Vascular Surgery, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany. Sebastian.Schoelch@uniklinikum-dresden.de.
2
Department of Gastrointestinal, Thoracic and Vascular Surgery, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
3
German Cancer Consortium (DKTK), Dresden, Germany.
4
German Cancer Research Center (DKFZ), Heidelberg, Germany.

Abstract

In most solid tumors, it is distant metastases rather than the primary tumor which limit the prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively invade the blood stream, attach to the endothelium in the target organ, invade the surrounding parenchyma, and form new tumors. Among many other capabilities such as migration or immune escape, CTCs require tumor-forming capacities and can therefore be considered stem cell-like cells. This chapter describes the enrichment and isolation of live CTCs from clinical blood samples for molecular characterization and other downstream applications.

KEYWORDS:

Circulating tumor cells; Distant metastases; EpCAM

PMID:
28986899
DOI:
10.1007/978-1-4939-7401-6_18
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center